How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Custom Peptide Synthesis Market
- By Peptide Type: Linear Peptides, Cyclic Peptides, Modified Peptides, Peptidomimetics, Branched Peptides
- By Synthesis Method: Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Recombinant Peptide Synthesis
- By Application: Pharmaceutical & Biotechnology Research, Diagnostic Peptides, Agricultural Peptides, Cosmetic Peptides, Food Industry Peptides
- By Purity Level: Crude Peptides, Partially Purified Peptides, High-Performance Liquid Chromatography (HPLC) Purified Peptides, Ultra-Pure Peptides
- By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Linear Peptides leads By Peptide Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 296 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Custom Peptide Synthesis Market report
A complete, evidence-based study - 12 chapters and 124 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Peptide Type 5
Synthesis Method 3
Application 5
Purity Level 4
End User 4
Companies profiled
Thermo Fisher Scientific
GenScript Biotech Corporation
Bachem Holding AG
CPC Scientific Inc.
Peptide Synthesis Services (PSS)
GL Biochem (Shanghai) Ltd.
CSBio Co. Ltd.
Sigma-Aldrich (Merck KGaA)
Peptide 2.0 Inc.
ChinaPeptides Co. Ltd.
Apeptide Co. Ltd.
Ontores Biotechnologies
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →GenScript Biotech Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bachem Holding AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →CPC Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Peptide Synthesis Services (PSS)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GL Biochem (Shanghai) Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →CSBio Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Sigma-Aldrich (Merck KGaA)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Peptide 2.0 Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →ChinaPeptides Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Apeptide Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Ontores Biotechnologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Abgent (a WuXi AppTec company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Bio-Synthesis Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →PeptiDream Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,770M by 2033 · 11.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Linear Peptides34.5
- Cyclic Peptides20.9
- Modified Peptides15.8
- Peptidomimetics17.6
- Branched Peptides11.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$789.7M → $1,700M · 10.1%
Europe$550.4M → $1,269M · 11.0%
Asia Pacific$502.5M → $1,195M · 11.4%
Latin America$311.1M → $735.3M · 11.4%
Middle East and Africa$239.3M → $643.2M · 13.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.582026
11.602027
11.612028
11.612029
11.622030
11.642031
11.662032
11.662033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific23.9
- GenScript Biotech Corporation13.0
- Bachem Holding AG12.0
- CPC Scientific Inc.6.3
- Peptide Synthesis Services (PSS)11.9
- GL Biochem (Shanghai) Ltd.4.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Peptide Type19.7%
Synthesis Method21.6%
Application11.9%
Purity Level33.7%
End User13.1%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.7
- Europe22.9
- Asia Pacific21.6
- Latin America13.3
- Middle East and Africa11.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 91 | 77 | 80 | 75 | 80 | 96 | 83 |
| GenScript Biotech Corporation | 70 | 73 | 84 | 92 | 69 | 85 | 79 |
| Bachem Holding AG | 67 | 84 | 70 | 78 | 81 | 68 | 75 |
| CPC Scientific Inc. | 67 | 57 | 66 | 73 | 59 | 79 | 67 |
| Peptide Synthesis Services (PSS) | 52 | 64 | 68 | 76 | 53 | 74 | 65 |
| GL Biochem (Shanghai) Ltd. | 65 | 51 | 67 | 62 | 54 | 65 | 61 |
| CSBio Co. Ltd. | 55 | 58 | 49 | 56 | 59 | 42 | 53 |
| Sigma-Aldrich (Merck KGaA) | 45 | 37 | 51 | 38 | 60 | 55 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- GenScript Biotech Corporation
- Bachem Holding AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ◐ | ◐ | ◐ | ✓ |
| GenScript Biotech Corporation | ✓ | − | ✓ | ✓ | ✓ | ◐ |
| Bachem Holding AG | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| CPC Scientific Inc. | ◐ | ◐ | − | ◐ | ◐ | ✓ |
| Peptide Synthesis Services (PSS) | ◐ | ◐ | ◐ | ✓ | − | ◐ |
| GL Biochem (Shanghai) Ltd. | ◐ | − | ◐ | ◐ | − | − |
| CSBio Co. Ltd. | − | ◐ | − | ◐ | − | − |
| Sigma-Aldrich (Merck KGaA) | − | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific83
2GenScript Biotech Corporation79
3Bachem Holding AG75
4CPC Scientific Inc.67
5Peptide Synthesis Services (PSS)65
6GL Biochem (Shanghai) Ltd.61
7CSBio Co. Ltd.53
8Sigma-Aldrich (Merck KGaA)48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificGenScript Biotech Corporation
Challenger2
Strong scale, closing on the leaders.
Bachem Holding AGCPC Scientific Inc.
Contender2
Focused players with pockets of strength.
Peptide Synthesis Services (PSS)GL Biochem (Shanghai) Ltd.
Niche2
Specialists in a single segment or region.
CSBio Co. Ltd.Sigma-Aldrich (Merck KGaA)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Peptide Type in North America, then scale across Custom Peptide Synthesis Market — a $290M beachhead inside a $4.01B market.
Beachhead (SOM)$290Mobtainable near-term
Serviceable (SAM)$1.60Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Linear Peptides
Best fit — highest urgency & budget in Peptide Type.
Economic buyer77 fit
Cyclic Peptides
Strong fit — clear ROI and a fast path to value.
End user67 fit
Modified Peptides
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Peptide Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Synthesis Method & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Peptide Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Custom Peptide Synthesis Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified39%
Sales qualified23%
Evaluation14%
Closed-won8%
$19.4KCAC
$111KLTV
5.7:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Custom Peptide Synthesis Market is a resilient opportunity — $5.61B by 2033, compounding at 5.5%.
TAM · 2025$3.66Btoday
TAM · 2033$5.61Bforecast
CAGR5.5%2027–2033
Cumulative$41.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.61BTotal addressable market
SAM$2.30BServiceable available market
SOM$431MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.5% CAGR
Demand compounds through 2033, outpacing GDP across Peptide Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Peptide Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.61BLarge & growingTAM by 2033 at 5.5% CAGR
$2.30BServiceable nowreachable with today’s model
$431MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.37BBear3.6% CAGR
$5.61BBase5.5% CAGR
$7.18BBull7.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Synthesis Method optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Custom Peptide Synthesis Market — a $4.59B market by 2033. Plan: grow share from 7.9% to 12.1%.
Market size · 2033$4.59Btotal addressable
Market CAGR6.5%2027–2033
Target share12.1%from 7.9% today
Revenue ambition$556Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.9% | 12.1% | On track |
| Revenue | $355M | $556M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 37.5% | 38.7% | At risk |
| Customer retention | 90.5% | 95.4% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Peptide Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Synthesis Method capability
A defensible second engine — invest in Synthesis Method to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Peptide Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Synthesis Method
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $78M capacity & capability investment
- Greenlight bolt-on M&A in Synthesis Method
- Authorise North America expansion plan
- Fund R&D program for Peptide Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Custom Peptide Synthesis Market conversation — a $4.29B market you can size, segment and defend in minutes.
Market size · 2033$4.29Btotal opportunity
Growth5.0%CAGR to 2033
Addressable buyers1,446+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Peptide Type
Goal Grow share in Peptide Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 3 mopayback period
$57K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificGenScript Biotech CorporationBachem Holding AGCPC Scientific Inc.Peptide Synthesis Services (PSS)GL Biochem (Shanghai) Ltd.CSBio Co. Ltd.Sigma-Aldrich (Merck KGaA)+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Custom Peptide Synthesis Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Custom Peptide Synthesis Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Custom Plastic Extrusion Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportCustom Precision Mold Component Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportCustom Procedure Trays (CPT) Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportCustom Procedure Trays, Packs & Kits Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportCustom Screen Printing Machine Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportCustom Socks Market
Market size, share, segmentation and regional forecast.
$522M market · 2025 base year
View reportCustom Software Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportCustom Thermoplastic Compounding Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportCustom Upholstered Chair Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportCustom- World Grinding Balls Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportCustomer Analytics Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportCustomer Engagement Tools Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.